Literature DB >> 16113422

Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?

Sanjay Sethi1.   

Abstract

Our understanding of the pathogenesis and consequences of acute exacerbations of chronic obstructive pulmonary disease (COPD) has increased considerably in the past decade. Several new lines of evidence support bacterial causation of approximately half of the exacerbations in COPD. Acquisition of new strains of bacterial pathogens in patients with COPD is associated with a substantial increase in risk of exacerbation. Bacterial pathogens are isolated in significant concentrations from bronchoscopic samples obtained during acute exacerbation. Neutrophilic airway inflammation is associated with isolation of bacterial pathogens from sputum. A specific immune response to the infecting strains of bacterial pathogens isolated from sputum during exacerbations has been demonstrated. Future work should strive to understand better the host-pathogen interaction that leads to an exacerbation and to develop novel therapeutic and preventive measures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16113422     DOI: 10.1513/pats.2306029

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  44 in total

Review 1.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 2.  Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?

Authors:  Robert P Schleimer
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

Review 4.  Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.

Authors:  Leopoldo N Segal; William N Rom; Michael D Weiden
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 5.  Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease.

Authors:  Scott H Randell
Journal:  Proc Am Thorac Soc       Date:  2006-11

6.  Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections.

Authors:  Tariq A Bhat; Suresh Gopi Kalathil; Paul N Bogner; Austin Miller; Paul V Lehmann; Thomas H Thatcher; Richard P Phipps; Patricia J Sime; Yasmin Thanavala
Journal:  J Immunol       Date:  2018-03-19       Impact factor: 5.422

Review 7.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

8.  Elevated CO2 suppresses specific Drosophila innate immune responses and resistance to bacterial infection.

Authors:  Iiro Taneli Helenius; Thomas Krupinski; Douglas W Turnbull; Yosef Gruenbaum; Neal Silverman; Eric A Johnson; Peter H S Sporn; Jacob I Sznajder; Greg J Beitel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.

Authors:  M Patricia George; Mouhamed Kannass; Laurence Huang; Frank C Sciurba; Alison Morris
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.